UK constumer healthcare association PAGB has appointed Bayer’s Mike Knowland as its new President. Knowland, who was ...
AlzeCure Pharma AB announced that its abstract on NeuroRestore ACD856 has been accepted for presentation at the AD/PD 2025 ...
The European Commission (EC) has approved the marketing authorisation for LAZCLUZE (lazertinib) in combination with RYBREVANT ...
Datapharm has announced its expansion into the United States through a new partnership with phactMI. The collaboration aims ...
The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a ...
Biofidelity and CellCarta have announced a strategic partnership to utilise Biofidelity’s Aspyre® Lung in global clinical ...
Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...
Owlstone Medical has announced a first close of $27 million (circa £22 million) in its Series E financing round. The round ...
Cambridge Cognition Holdings plc has expanded its partnership with Actinogen Medical Limited for the phase 2b/3 XanaMIA Alzheimer’s disease trial. Building on the successful integration of Cambridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback